What is Vraylar

Vraylar is a brand (trade) name for cariprazine, which may be taken in to treat schizophrenia, bipolar I disorder, or major depressive disorder.

The precise mechanism of action of Vraylar (cariprazine) is unknown; however, experts believe it is mediated by a mix of partial agonist activity at central dopamine D2 and serotonin 5-HT1A receptors and serotonin Type 2 (5HT2A) receptor antagonism. Cariprazine produces two main metabolites, both of which are active.

Vraylar is an atypical antipsychotic, which is a type of medication. Atypical means an antipsychotic is less likely than other, typically older, antipsychotics to cause extrapyramidal symptoms and tardive dyskinesia.